The Global Asthma and COPD Market was valued at US$ 39,021.2 Mn in 2016 and is expected to reach US$ 56,507.7 Mn by 2027, expanding at a CAGR of 4% from 2021 to 2027.
Asthma is a chronic respiratory disease that blocks the airways of the lungs due to inflammation, mucus production, and muscle strengthening. Chronic obstructive pulmonary disease (COPD) is a blockage of the airways that causes breathing difficulties, the main cause being cigarette smoking. Chronic obstructive pulmonary disease (COPD) is characterized by a constant blockage of airflow in the lungs, causing more abnormal sputum than a “smoker’s cough” or chronic cough and breathing difficulties. Symptoms of COPD include coughing, shortness of breath (shortness of breath) and wheezing, phlegm, chest infections, weight loss, fatigue, and swelling of the ankles.
(Get 15% Discount on Buying this Report)
A full report of Global Asthma and COPD Market is available at: https://www.orionmarketreports.com/asthma-and-copd-market/55802/
Market Segments
By Diseases
- COPD
- Asthma
By Medication Class
- Combination Products
- Leukotriene Antagonists (LTA)
- Inhaled Corticosteroids (ICS)
- Anticholinergics
- Short-Acting Beta Agonists(SABA)
- Long-Acting Beta Agonists (LABA)
- Others
Key Players
Major players operating in global asthma and COPD market include AstraZeneca, Novartis AG, GlaxoSmithKline plc, Merck & Co., Verona Pharma plc, Regeneron Pharmaceuticals, Inc., GlaxoSmithKline plc, and Boehringer Ingelheim GmbH.
Scope of the Report
The research study analyzes the global Asthma and COPD industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Asthma and COPD Market Report
1. What was the Asthma and COPD Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of the Asthma and COPD Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Asthma and COPD Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Asthma and COPD market.
- The market share of the global Asthma and COPD market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Asthma and COPD market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Asthma and COPD market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
